Active Biotech AB Employee Directory
Biotechnology ResearchSkåne, Sweden11-50 Employees
Active Biotech AB is a biotechnology company focused on developing first-in-class immunomodulatory therapies for oncology and immunology with high unmet medical need. Following a portfolio refocus, the company aims to move programs into clinical development and then advance them internally or pursue partnerships. The portfolio centers on tasquinimod and laquinimod, small-molecule modulators that influence myeloid immune cell function, with tasquinimod studied in multiple myeloma and laquinimod progressing toward ophthalmic applications for non-infectious uveitis. Naptumomab, a targeted cancer immunotherapy, is partnered with NeoTX Therapeutics for a phase Ib/II program in advanced solid tumors. A notable recent development is the 2024 collaboration with MD Anderson Cancer Center to conduct a tasquinimod clinical study in myelofibrosis. The company is headquartered in Lund, Skåne, and is listed on NASDAQ Stockholm.
1-888-653-2347 
support@leadiq.com 
